Skip to main navigation Skip to search Skip to main content

Host serum-circulating flavivirus NS1 co-opts mosquito miRNA processing to suppress early immune defense

  • Yifei Li
  • , Chunlai Cui
  • , Jinjin Ding
  • , Yiguan Wang
  • , Jiaqi Yun
  • , Fang Li
  • , Sibao Wang*
  • *Corresponding author for this work
  • New Cornerstone Science Laboratory
  • CAS - Center for Excellence in Molecular Plant Sciences
  • University of Chinese Academy of Sciences
  • School of Life Sciences
  • East China Normal University

Research output: Contribution to journal › Article › peer-review

Abstract

Flaviviruses pose growing global health threats and are transmitted by Aedes mosquitoes. Yet, how these viruses overcome early mosquito immunity remains unclear. Here, we reveal a cross-host immune evasion strategy in which the flavivirus NS1 protein, abundantly secreted into infected human serum, is taken up by mosquitoes during blood feeding and rapidly internalized into midgut epithelial cells—prior to viral replication. NS1 hijacks the mosquito spliceosome-associated factor Prp19 to promote miR-275-5p maturation, which suppresses the caspase gene CASPS19, blocking apoptosis and enabling early viral replication. Engineered mosquitoes expressing a miR-275 sponge show enhanced resistance to dengue and Zika viruses. These findings uncover a mechanism by which a viral protein presented in infected host blood reprograms vector gene regulation, establishing a paradigm of cross-species immune manipulation by flaviviruses.

Original languageEnglish
Article number6535
JournalNature Communications
Volume17
Issue number1
DOIs
StatePublished - Dec 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Host serum-circulating flavivirus NS1 co-opts mosquito miRNA processing to suppress early immune defense'. Together they form a unique fingerprint.

Cite this